Bladder Cancer

>

Latest News

Simple line illustration of a bladder on a gold background
Antihistamines Linked to Improved Survival in Urothelial Carcinoma Treated with Immunotherapy

March 12th 2025

Adding antihistamines to atezolizumab led to a 46% OS rate and a 23% PFS rate in metastatic urothelial carcinoma.

a blue and black graphic of the body with the urothelium highlighted
Enfortumab Vedotin and Pembrolizumab Effective in Treating Primary UTUC Lesions

February 15th 2025

dark blue background with a yellow outline of a bladder
Real-World Data Support Enfortumab Vedotin for Urothelial Carcinoma Treatment

February 15th 2025

yellow notepad with side effects written in red and medications on the left-hand side
Certain AEs May Indicate Improved PFS With Enfortumab Vedotin for Urothelial Carcinoma

February 14th 2025

illustration of a bladder with two doctors in lab coats standing next to it
Enfortumab Vedotin May Be Safe in Ultra-Elderly Patients With Urothelial Carcinoma

February 14th 2025

Video Series
Video Interviews
Podcasts

More News